{"id":4766,"date":"2022-12-19T00:00:11","date_gmt":"2022-12-19T00:00:11","guid":{"rendered":"https:\/\/eu.bd.com\/iv-news\/?p=4766"},"modified":"2025-06-04T14:25:51","modified_gmt":"2025-06-04T12:25:51","slug":"how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps","status":"publish","type":"post","link":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/","title":{"rendered":"How can you help reduce the risk of severe adverse events with TIVA syringe pumps?"},"content":{"rendered":"<p><span data-contrast=\"auto\">On April 5th, Dr. Emiliano Tognoli from the National Cancer Institute of Milan spoke at a BD webinar held in Milan, Italy.\u00a0\u00a0<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">The aim was to raise awareness and explain the risks associated with infusion systems using disposable syringes and dedicated administration sets during total intravenous anaesthesia (TIVA), as well as providing recommendations to help reduce related adverse clinical effects and events.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Using compatible syringes and dedicated TIVA infusion sets can help ensure flow rate and dose accuracy<\/span><sup><span data-contrast=\"auto\">1<\/span><\/sup><span data-contrast=\"auto\">. <\/span><b><span data-contrast=\"auto\">Incompatible syringes may cause improper pump operation<\/span><\/b><span data-contrast=\"auto\">, resulting in inaccurate fluid delivery, insufficient detection of occlusion (obstruction) and lack of flow continuity<\/span><sup><span data-contrast=\"auto\">2<\/span><\/sup><span data-contrast=\"auto\">.\u00a0<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">A lack of flow continuity can result in excessive delays in therapy, over-infusion or under-infusion, which have been shown to potentially lead to abnormal or unstable blood pressure, anxiety from loss of sedation and increased pain in critically ill children<\/span><sup><span data-contrast=\"auto\">2<\/span><\/sup><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Equally important <\/span><b><span data-contrast=\"auto\">is the use of an administration set designed for TIVA<\/span><\/b><sup><span data-contrast=\"auto\">3<\/span><\/sup><b><span data-contrast=\"auto\">, <\/span><\/b><span data-contrast=\"auto\">whose specific characteristics help enable infusion safety. The set should be made out of low-absorption material to prevent under-infusion of anaesthesia.\u00a0<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">It should be equipped with an anti-siphon valve to prevent secondary boluses in the same line as anaesthesia<\/span><sup><span data-contrast=\"auto\">3<\/span><\/sup><span data-contrast=\"auto\">. And with an anti-reflux valve on the line dedicated to gravity infusion<\/span><sup><span data-contrast=\"auto\">3<\/span><\/sup><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Together, all these aspects help ensure the safety of TIVA<\/span><b><span data-contrast=\"auto\"> infusions for patients and efficient workflows for anaesthetists.<\/span><\/b><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n\t\t\t\t\t<div class=\"gated_content\" id=\"gated_content-638e2b57dbe16\">\n\t\t\t\t\t\t<div class=\"labelform notice-box margin-full\">\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<i class=\"fa fa-exclamation-triangle\" aria-hidden=\"true\"><\/i>\n\t\t\t\t\t\t\t\tBecome a VAMbassador to get access to the full article\t\t\t\t\t\t\t<\/p>\n\n\t\t\t\t\t\t\t<div class=\"loginwrapper\">\n\t\t\t\t\t\t\t\t<form name=\"loginform\" id=\"loginform\" method=\"post\">\n\n\t\t\t\t\t\t\t\t\t<p class=\"login-username\">\n\t\t\t\t\t\t\t\t\t\t<label for=\"user_login\"><\/label>\n\t\t\t\t\t\t\t\t\t\t<input required type=\"email\" name=\"log\" placeholder=\"Email address\" id=\"user_login\" class=\"input\" size=\"20\">\n\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t<p class=\"login-password\">\n\t\t\t\t\t\t\t\t\t\t<label for=\"user_pass\"><\/label>\n\t\t\t\t\t\t\t\t\t\t<input required type=\"password\" name=\"pwd\" placeholder=\"Password\" id=\"user_pass\" class=\"input\" size=\"20\">\n\t\t\t\t\t\t\t\t\t\t<i class='fa fa-eye showpwd'><\/i>\n\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t<p class=\"login-submit\">\n\t\t\t\t\t\t\t\t\t\t<input type=\"submit\" name=\"wp-submit\" id=\"wp-submit\" class=\"button button-primary\" value=\"Login\">\n\t\t\t\t\t\t\t\t\t\t<input type=\"hidden\" name=\"redirect_to\" value=\"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/#gated_content-638e2b57dbe16\">\n\t\t\t\t\t\t\t\t\t<\/p>\n\n\t\t\t\t\t\t\t\t\t<div class=\"aa_error hide\">\n\t\t\t\t\t\t\t\t\t\t<p><\/p>\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\t\t<\/form>\n\n\t\t\t\t\t\t\t\t<div class='extralink'>\n\t\t\t\t\t\t\t\t\t<a class=\"forgot\" href=\"https:\/\/eu.bd.com\/iv-news\/it\/password-persa\/\">\n\t\t\t\t\t\t\t\t\t\tForgot your password?\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<br \/>\n\t\t\t\t\t\t\t\t\t<a class=\"register\" href=\"https:\/\/eu.bd.com\/iv-news\/fr\/inscription\/\">\n\t\t\t\t\t\t\t\t\t\tNot registered yet? <strong> Sign up <\/strong>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<div class=\"content\" style=\"display:none;\">\n\t\t\t\t\t\t\t<p><iframe title=\"How can you help reduce the risk of severe adverse events with TIVA syringe pumps?\" width=\"640\" height=\"360\" data-src=\"https:\/\/www.youtube.com\/embed\/0L_cfsRiccQ?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe><\/p>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\n","protected":false},"excerpt":{"rendered":"<p>On April 5th, Dr. Emiliano Tognoli from the National Cancer Institute of Milan spoke at a BD webinar held in&#8230;<\/p>\n","protected":false},"author":8,"featured_media":4461,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5618,1],"tags":[],"class_list":["post-4766","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gated-content","category-news-innovation","speciality-anesthesiology","contenttype-video","target-clinical-pharmacy","target-doctor"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>How can you help reduce the risk of severe adverse events with TIVA syringe pumps?<\/title>\n<meta name=\"description\" content=\"Get recommendations to help ensure patient safety when using TIVA syringe pumps during this BD webinar held in Milan, Italy on 5 April, 2022.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How can you help reduce the risk of severe adverse events with TIVA syringe pumps?\" \/>\n<meta property=\"og:description\" content=\"Get recommendations to help ensure patient safety when using TIVA syringe pumps during this BD webinar held in Milan, Italy on 5 April, 2022.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/\" \/>\n<meta property=\"og:site_name\" content=\"BD IV News\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-19T00:00:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-04T12:25:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2022\/07\/202203-MDS22-ITA_IT-TIVA_pump_webinar-1222.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1220\" \/>\n\t<meta property=\"og:image:height\" content=\"520\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Camille Suarez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Camille Suarez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/news-innovation\\\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/news-innovation\\\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\\\/\"},\"author\":{\"name\":\"Camille Suarez\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/person\\\/133274b3c3f2b1e2a25492760340ccf2\"},\"headline\":\"How can you help reduce the risk of severe adverse events with TIVA syringe pumps?\",\"datePublished\":\"2022-12-19T00:00:11+00:00\",\"dateModified\":\"2025-06-04T12:25:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/news-innovation\\\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\\\/\"},\"wordCount\":242,\"publisher\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/news-innovation\\\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/202203-MDS22-ITA_IT-TIVA_pump_webinar-1222.png\",\"articleSection\":[\"Gated Content\",\"News and innovation\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/news-innovation\\\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\\\/\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/news-innovation\\\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\\\/\",\"name\":\"How can you help reduce the risk of severe adverse events with TIVA syringe pumps?\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/news-innovation\\\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/news-innovation\\\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/202203-MDS22-ITA_IT-TIVA_pump_webinar-1222.png\",\"datePublished\":\"2022-12-19T00:00:11+00:00\",\"dateModified\":\"2025-06-04T12:25:51+00:00\",\"description\":\"Get recommendations to help ensure patient safety when using TIVA syringe pumps during this BD webinar held in Milan, Italy on 5 April, 2022.\",\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/news-innovation\\\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/news-innovation\\\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\\\/#primaryimage\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/202203-MDS22-ITA_IT-TIVA_pump_webinar-1222.png\",\"contentUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/202203-MDS22-ITA_IT-TIVA_pump_webinar-1222.png\",\"width\":1220,\"height\":520,\"caption\":\"ridurre il rischio di eventi avversi gravi durante l\u2019infusione con pompa TIVA\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#website\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/\",\"name\":\"BD IV News\",\"description\":\"Your source of information on intravenous therapy, medication delivery and vascular access management.\",\"publisher\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#organization\",\"name\":\"BD IV News\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/BD-Master-Logo-on-Warm-White-512X512px.png\",\"contentUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/BD-Master-Logo-on-Warm-White-512X512px.png\",\"width\":512,\"height\":512,\"caption\":\"BD IV News\"},\"image\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/person\\\/133274b3c3f2b1e2a25492760340ccf2\",\"name\":\"Camille Suarez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f50a86470bf0edfb5227a77db11a6f6ab98f270489a78660886c4d7bf008f2bd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f50a86470bf0edfb5227a77db11a6f6ab98f270489a78660886c4d7bf008f2bd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f50a86470bf0edfb5227a77db11a6f6ab98f270489a78660886c4d7bf008f2bd?s=96&d=mm&r=g\",\"caption\":\"Camille Suarez\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"How can you help reduce the risk of severe adverse events with TIVA syringe pumps?","description":"Get recommendations to help ensure patient safety when using TIVA syringe pumps during this BD webinar held in Milan, Italy on 5 April, 2022.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/","og_locale":"en_GB","og_type":"article","og_title":"How can you help reduce the risk of severe adverse events with TIVA syringe pumps?","og_description":"Get recommendations to help ensure patient safety when using TIVA syringe pumps during this BD webinar held in Milan, Italy on 5 April, 2022.","og_url":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/","og_site_name":"BD IV News","article_published_time":"2022-12-19T00:00:11+00:00","article_modified_time":"2025-06-04T12:25:51+00:00","og_image":[{"width":1220,"height":520,"url":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2022\/07\/202203-MDS22-ITA_IT-TIVA_pump_webinar-1222.png","type":"image\/png"}],"author":"Camille Suarez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Camille Suarez","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/#article","isPartOf":{"@id":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/"},"author":{"name":"Camille Suarez","@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/person\/133274b3c3f2b1e2a25492760340ccf2"},"headline":"How can you help reduce the risk of severe adverse events with TIVA syringe pumps?","datePublished":"2022-12-19T00:00:11+00:00","dateModified":"2025-06-04T12:25:51+00:00","mainEntityOfPage":{"@id":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/"},"wordCount":242,"publisher":{"@id":"https:\/\/eu.bd.com\/iv-news\/#organization"},"image":{"@id":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/#primaryimage"},"thumbnailUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2022\/07\/202203-MDS22-ITA_IT-TIVA_pump_webinar-1222.png","articleSection":["Gated Content","News and innovation"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/","url":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/","name":"How can you help reduce the risk of severe adverse events with TIVA syringe pumps?","isPartOf":{"@id":"https:\/\/eu.bd.com\/iv-news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/#primaryimage"},"image":{"@id":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/#primaryimage"},"thumbnailUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2022\/07\/202203-MDS22-ITA_IT-TIVA_pump_webinar-1222.png","datePublished":"2022-12-19T00:00:11+00:00","dateModified":"2025-06-04T12:25:51+00:00","description":"Get recommendations to help ensure patient safety when using TIVA syringe pumps during this BD webinar held in Milan, Italy on 5 April, 2022.","inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/how-can-you-help-reduce-the-risk-of-severe-adverse-events-with-tiva-syringe-pumps\/#primaryimage","url":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2022\/07\/202203-MDS22-ITA_IT-TIVA_pump_webinar-1222.png","contentUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2022\/07\/202203-MDS22-ITA_IT-TIVA_pump_webinar-1222.png","width":1220,"height":520,"caption":"ridurre il rischio di eventi avversi gravi durante l\u2019infusione con pompa TIVA"},{"@type":"WebSite","@id":"https:\/\/eu.bd.com\/iv-news\/#website","url":"https:\/\/eu.bd.com\/iv-news\/","name":"BD IV News","description":"Your source of information on intravenous therapy, medication delivery and vascular access management.","publisher":{"@id":"https:\/\/eu.bd.com\/iv-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eu.bd.com\/iv-news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/eu.bd.com\/iv-news\/#organization","name":"BD IV News","url":"https:\/\/eu.bd.com\/iv-news\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/logo\/image\/","url":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/04\/BD-Master-Logo-on-Warm-White-512X512px.png","contentUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/04\/BD-Master-Logo-on-Warm-White-512X512px.png","width":512,"height":512,"caption":"BD IV News"},"image":{"@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/person\/133274b3c3f2b1e2a25492760340ccf2","name":"Camille Suarez","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/f50a86470bf0edfb5227a77db11a6f6ab98f270489a78660886c4d7bf008f2bd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f50a86470bf0edfb5227a77db11a6f6ab98f270489a78660886c4d7bf008f2bd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f50a86470bf0edfb5227a77db11a6f6ab98f270489a78660886c4d7bf008f2bd?s=96&d=mm&r=g","caption":"Camille Suarez"}}]}},"lang":"en","translations":{"en":4766,"it":4371,"de":4833},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts\/4766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/comments?post=4766"}],"version-history":[{"count":6,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts\/4766\/revisions"}],"predecessor-version":[{"id":8882,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts\/4766\/revisions\/8882"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/media\/4461"}],"wp:attachment":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/media?parent=4766"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/categories?post=4766"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/tags?post=4766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}